logo-loader

Stagecoach upgraded after ‘overreaction’ to outlook

Stagecoach, Intertek, IMI, Lancashire Holdings, and St James Place were all in Thursday’s broker spotlight.

stagecoach-bus.jpg
The bus and train Group saw an upgrade and two (slight) downgrades

You wait for a broker recommendation for a bus company, then three come along at once.

Stagecoach Group was in the spotlight on Thursday with an upgrade and two (slight) downgrades.

Citigroup raised its recommendation to ‘buy’ from ‘neutral’, while Deutsche Bank and Barclays - which already rate the company as ‘buy’ and ‘overweight’ respectively - revised down their price targets.

Deutsche cuts its target to 390p from 460p, and Barclays’ drops to 340p from 400p.

It comes after the coach and rail group’s financial results for the first half year, which included what Deutsche called “surprisingly weak commentary”.

Stagecoach shares tumbled around 14% yesterday.

Citi, in its upgrade note, meanwhile says there’s been an overreaction to the company’s weaker guidance.

Elsewhere, Citi downgraded product tester Intertek (LON:ITRK) to ‘sell’ as it highlighted what it described as “US dollar distortions”.

Morgan Stanley has downgraded IMI (LON:IMI) to ‘equal weight’  from ‘overweight’.

RBC Capital has downgraded speciality insurance group Lancashire Holdings (LON:LRE) to ‘underperform’ from ‘sector perform’.

It also downgraded wealth manager St James Place (LON:STJ) to ‘sector perform’ from ‘outperform’.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Polymers specialist Itaconix 'accelerating' revenue post trading update

Polymers specialist Itaconix (LON:ITX) tells Proactive London it will accelerate “key revenue opportunities” on the back of its figures announcement today. CEO John Shaw acknowledges Itaconix's full-year sales are below current market expectations but explains this is due to fast company growth...

3 hours, 10 minutes ago

RNS

Director/PDMR Shareholding

1 week, 1 day ago

Transaction in Own Shares

1 week, 2 days ago

Director/PDMR shareholding

1 week, 2 days ago

Transaction in Own Shares

1 week, 3 days ago

Transaction in Own Shares

1 week, 4 days ago

Director/PDMR Shareholding

2 weeks, 1 day ago

2 min read